Prof. Dr. Stefan Dübel
Antibody Engineering, Phage Display, Intrabodies, in vitro Evolution, Synthetic Biology, Biosensors, Sneaking Ligands, Hyperphage, SARS-CoV-2 neutraliszing antibodies
1978-1982 Studies of Biology at the Universities of Mainz and Heidelberg, Germany
1982-1983 Diploma thesis in Botany at the Max-Planck Institute for Cell Biology in Ladenburg, Germany on "Developmental Biology of the Green Algae Acetabularia"
1984-1985 Zivildienst: Research on "Diagnostic Tools for Autoimmune Diseases" at the Institute of Immunology, University of Heidelberg.
1986-1989 PhD thesis at the Centre for Molecular Biologiy Heidelberg (ZMBH) on "Cell Cycle Regulation and Cell Differentiation in the Coelenterate Hydra", Promotion (Dr. rer. nat.) summa cum laude.
8/1989-7/1991 Post-Doc at the German Cancer Research Centre, Heidelberg (DKFZ) with a project on "Generation and Screening of E. coli Libraries of Recombinant Antibodies"
1/1992-7/1992 Work on "Recombinant Antibodies Against TNF Receptor" at the Institute of Cell Biology and Immunology, University of Stuttgart, Germany
8/1992-9/1996 Work on "Recombinant Antibodies, Immunotoxins and Phage Display Screening Technologies" at the German Cancer Research Centre, Heidelberg (DKFZ)
1996-2001 Group leader of the "Recombinant Antibody Unit" at the Department of Molecular Genetics, University of Heidelberg
6/1997 Habilitation (Faculty of Biology), University of Heidelberg
2/2001 Appointed "Hochschuldozent" at the University of Heidelberg
2001-2002 CSO and Member of the Directory Board of LifeBits AG
Oct 2002 - today Full Professor and Director of the Department of Biotechnology, Technical University of Braunschweig, Germany
1989 "Stipendium zur Förderung des herausragenden wissenschaftlichen Nachwuchses" des Deutschen Krebsforschungszentrums Heidelberg